Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGS649 in refractory endometriosis
NCT01116440Phase 2Terminated
- Sponsor
- Mereo BioPharma
- Start
- Apr 2010
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in endometriosis comparing BGS649 + Levora 28 with Placebo + Levora 28 (2 arms). Primary endpoint: Mean Change in Baseline to Week 12 in Numeric Rating Scale Pelvic Pain Score. Started Apr 2010; status: terminated.
02
Drugs
leflutrozole
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT01116440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01116440.